Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST
Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. Using Aiforia’s distinct AI development platform, Aiforia® Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. The developed AI models will be implemented in their clinical workflow, with the intention of adopting additional AI applications within women’s health.
“Our partnership with Aiforia marks a significant step forward in enhancing our diagnostic capabilities, particularly in the critical, high-volume application of cervical cancer”, says Dr. Marco Spagnoli, laboratory director. “By leveraging the power of Aiforia® Create, we aim to develop specialized AI models that will improve the efficiency and accuracy of our laboratory workflow. This collaboration is key to our strategic goal of increasing our lab's volume and seizing new business opportunities, ensuring we can provide faster, higher-quality diagnostics to a greater number of patients”, he continues.
“Diagnostic laboratories in the field of anatomical pathology require tools that can be tailored to support any image analysis application the laboratory has, and to handle massive datasets with high consistency and speed. Aiforia® Create is precisely that, as it provides our customers an unparalleled environment to rapidly develop and deploy specialized AI models that drive workflow efficiency and accuracy, to ultimately bring treatments to patients faster”, says Jukka Tapaninen, CEO of Aiforia. “We look forward to a long-term partnership with the laboratory La Fontana”, he continues.
Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.
Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient.
Find out more at www.aiforia.com
Back to all blog posts
